Healthcare and Life Science
CMR Surgical raises more than $200m to accelerate growth in US and globally
Global surgical robotics company CMR Surgical in Cambridge has closed a funding round of more than $200 million to underpin worldwide expansion – notably in the US.The haul has been raised through a combination of equity and debt capital to support the company’s ambitious growth plans.T...
Cambridge Innovation Capital co-leads $31M seed financing for TRIMTECH Therapeutics to advance neurodegenerative disease treatments
Cambridge Innovation Capital (CIC), a leading investor in life sciences and deep tech companies, today announces its role as a co-lead investor in TRIMTECH Therapeutics’ $31 million (£25 million) seed funding round. The financing round, which was oversubscribed, was also co-led by SV He...
Epitopea announces license and research collaboration agreement with MSD to identify cryptigenTM tumor-specific antigens
Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to identify CryptigenTM tumor-specif...
Sphere Bio expands APAC distribution network to strengthen presence in region
Operational scale-up accelerates global growth strategy to increase regional access and technical supportCambridge, UK, 9th April 2025: Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, announces a significant ...
The 8Cs of smart business expansion: A simple framework for going big, the right way
By Gary Jennings, Innovation Director, The EpiCentre.
The role of AI and omnichannel strategies in healthcare marketing
Co-authored by Jose Maria (Chema) Guido Avila, SanofiThe pharmaceutical industry is at a pivotal moment. As the world grows more digital and patients become more informed, traditional marketing strategies are losing their effectiveness. Doctors are overwhelmed with information, and pati...
ELRIG appoints Dr Del Trezise as Chair
Cambridge, UK, 8 April 2025: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board. In this role, he will lead ELRIG’s mission to foster collaboration, innovation, and knowledge-sh...
IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platformMännedorf, Switzerland, April 8, 2025 – IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostic...
AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing
AstraZeneca announces an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance life sciences in China. ...
World-first trial indicates immunosuppression may help treat Parkinson’s
A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease, according to results presented this weekend at the world’s most prestigious neurodegeneration conference AD/PD. ...